Last reviewed · How we verify
TD0019 oral capsule — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
TD0019 oral capsule (TD0019 oral capsule) — Sao Thai Duong Joint Stock Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| TD0019 oral capsule TARGET | TD0019 oral capsule | Sao Thai Duong Joint Stock Company | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- TD0019 oral capsule CI watch — RSS
- TD0019 oral capsule CI watch — Atom
- TD0019 oral capsule CI watch — JSON
- TD0019 oral capsule alone — RSS
Cite this brief
Drug Landscape (2026). TD0019 oral capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/td0019-oral-capsule. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab